SMi Reports: The agenda and speaker line-up for the upcoming Pharmaceutical Microbiology East Coast Conference, which will convene in Boston, USA April 29th and 30th, 2020 has been released. The pharmaceutical microbiology industry has […]
SMi Reports: Robert Young from Blue Burgundy to lead AI in Drug Discovery 2020 workshop in March 2020. SMi Group’s inaugural AI in Drug Discovery conference will take place on 16th-17th March in London. As […]
SMi Reports: Registration has opened for the 7th annual Pre-Filled Syringes conference taking place on 27th – 28th April 2020 in Boston. SMi is proud to announce that the 7th annual Pre-Filled Syringes conference will […]
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizerand Shionogi Limited as shareholders, today announced that the company will be developing the investigational broadly neutralising antibody (bNAb) N6LS for the treatment […]
Novartis has announced its heart failure drug Entresto (sacubitril/valsartan) causes a greater reduction in heart failure hospitalisation and cardiovascular (CV) deaths compared to valsartan alone in women with heart failure with preserved ejection fraction (HFpEF). […]